Transrectal ultrasound-guided needle biopsy of the prostate is routinely performed to diagnose prostate cancer. We performed a prospective study to assess the pain and identify risk factors of pain ...

Pune, India, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global transrectal ultrasound market size was valued at USD 228 million in 2022 and is expected to be worth USD 241.2 million in 2023. The market is ...

We prospectively investigated the clinical parameters that influenced pain during prostate biopsies. From 12 hospitals 1781 patients were enrolled. The patients completed a visual analogue scale ...

Extended analysis of a validated urine-exosome signature to predict high grade prostate cancer on initial biopsy: Performance across multiple sub-groups. This is an ASCO Meeting Abstract from the 2016 ...

(MENAFN- EIN Presswire) Increase in prevalence of prostate cancer, rise in adoption of imaging systems in the healthcare facility, introduction of technologically advanced systems. WILMINGTON, DE, ...

April 19, 2010 (Barcelona, Spain) — Efforts to convince urologists to switch to penicillin for prophylaxis for transrectal ultrasonography of the prostate (TRUSP) should be abandoned, UK investigators ...

Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate Purpose: ...

Market OverviewThe global transrectal ultrasound (TRUS) market is expected to grow at a steady CAGR of around 6% during the forecast period. The market growth is driven by the rising prevalence of ...

MADRID — For patients who undergo prostate biopsy, patient-reported adverse effects and attitudes are similar when either a transperineal approach or the more traditional transrectal approach is used, ...

> Researchers from Zurich are using focused ultrasound to non-invasively destroy cancerous brain tissue through a patient's intact skull. The treatment was conducted at the Focused Ultrasound Center ...